newsfilter
← Latest News
ClinicalTrials.gov·

A Study of Mavacamten in Participants With HFpEF and Chronic Elevation of cTnI and/or NT-proBNP - NCT04766892

Frequency and severity of treatment-emergent adverse events, adverse events of special interest, and serious adverse events., Mavacamten effect on cTnI levels (at rest), Mavacamten effect on NT-proBNP levels (at rest)